ATLASAxsome Therapeutics (AXSM) earnings date: Nov 2, 2026
Axsome Therapeutics (AXSM) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, before the open. Analysts expect EPS of -$0.68.
Source: company filings and exchange data · Updated Nov 2, 2026
Axsome Therapeutics reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Axsome Therapeutics. You can switch it off at any time.
Alert me before AXSM reportsFree to start. Creating an account takes under a minute.
AXSM earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.68 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +26.5% |
| Average move around a report | ±3.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Axsome Therapeutics earnings history: last 5 reports
Axsome Therapeutics last reported on Aug 10, 2026: EPS of -$0.99 against an estimate of -$0.78 (-26.9% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.78 | -$0.99 | -26.9% | Miss | +1.4% |
| May 22, 2026 | $1.34 | $1.78 | +32.8% | Beat | +0.2% |
| May 4, 2026 | -$0.86 | -$1.26 | -46.5% | Miss | +8.0% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | -1.6% |
| Feb 23, 2026 | -$0.73 | -$0.56 | +23.3% | Beat | -7.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on AXSM before the report
| Last price | $144.43 (+0.7%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 49% |
| Likely 1-month range (50%) | $133.27 – $155.70 |
| Normal 1-day range (±1σ) | ±2.7% |
These figures come from the same calibrated model and valuation as the Axsome Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for AXSM
See the fair value, the probability range and the earnings history of Axsome Therapeutics on its ATLAS page.
Axsome Therapeutics (AXSM) stock analysisPlans from €3.99 a month.
Axsome Therapeutics earnings: frequently asked questions
When does Axsome Therapeutics (AXSM) report earnings?
Axsome Therapeutics is scheduled to report on Monday, November 2, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AXSM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.68 per share (USD). Estimates can change before the report.
How often does AXSM beat earnings estimates?
Of its last 5 reports with a recorded result, Axsome Therapeutics beat the EPS estimate 3 times; the average surprise was +26.5%. Past results do not predict the next one.
How much does AXSM move around earnings?
Over its last 5 reports the stock moved an average of 3.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Axsome Therapeutics beat earnings estimates last quarter?
Axsome Therapeutics last reported on Aug 10, 2026: EPS of -$0.99 against an estimate of -$0.78 (-26.9% surprise), a miss.
How much does AXSM usually move in a day?
On a normal trading day the ATLAS model puts AXSM’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer